We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Starts Review of Pfizer/BioNTech COVID-19 Vaccine Candidate
EMA Starts Review of Pfizer/BioNTech COVID-19 Vaccine Candidate
The European Medicines Agency (EMA) began its second expedited review of a COVID-19 vaccine candidate, starting its evaluation of data for Pfizer/BioNTech’s vaccine hopeful BNT162b2 on Tuesday.